Watch MDXG. Know when insiders buy.
One email the day a filing lands. Free.
MDXG
MIMEDX GROUP, INC.
4.77
+0.08 +1.71%
USD · close Sep 18
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
37
FLAG · shorts 37
Insiders, 90 days
0
no open-market filings in 90 days
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $695.3MP/E 119.2DIV YIELD —FCF YIELD —REV TTM $355.2M −2.4%NET INCOME $6.2M −80.6%NET CASH $117.8M52W 3.09 – 7.96SEC XBRL · TTM TO Invalid Date
Financials
By quarter
| Period | Revenue | YoY | Gross margin | Operating income | Net income | YoY | EPS | Op. cash flow | Capex | Free cash flow | Filed |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Q2 2026 · Jun 30 | $64.4M | −34.7% | 69.0% | −$18.5M | −$14.8M | −254.3% | -0.10 | −$10M | — | — | Jul 29 |
| Q1 2026 · Mar 31 | $59M | −33.1% | 70.6% | −$16M | −$10.9M | −254.6% | -0.07 | $1.9M | — | — | Apr 29 |
| Q4 2025 · Dec 31derived | $118.1M | +27.1% | 83.9% | $21.1M | $15.2M | +104.2% | 0.10 | $25M | — | — | Feb 25 |
| Q3 2025 · Sep 30 | $113.7M | +35.3% | 83.5% | $22.2M | $16.7M | +106.9% | 0.11 | $29.3M | — | — | Oct 29 |
| Q2 2025 · Jun 30 | $98.6M | +13.1% | 81.1% | $12.4M | $9.6M | −45.4% | 0.06 | $14.4M | — | — | Jul 29 |
| Q1 2025 · Mar 31 | $88.2M | +4.1% | 81.2% | $8.3M | $7M | −24.2% | 0.05 | $5.3M | — | — | Apr 29 |
| Q4 2024 · Dec 31derived | $92.9M | +7.0% | 81.8% | $11.1M | $7.4M | −86.1% | 0.05 | $18.8M | — | — | Feb 25 |
| Q3 2024 · Sep 30 | $84.1M | +2.9% | 81.8% | $11.2M | $8.1M | −5.1% | 0.05 | $19.6M | — | — | Oct 29 |
| Q2 2024 · Jun 30 | $87.2M | — | 83.0% | $23.4M | $17.6M | — | 0.12 | $21.8M | — | — | Jul 30 |
| Q1 2024 · Mar 31 | $84.7M | — | 84.7% | $13.2M | $9.3M | — | 0.06 | $6M | — | — | Apr 30 |
| Q4 2023 · Dec 31derived | $86.8M | — | 84.1% | $15.5M | $53.5M | — | 0.37 | $10.3M | $427K | $9.8M | Feb 25 |
| Q3 2023 · Sep 30 | $81.7M | — | 81.9% | $11.1M | $8.5M | — | 0.06 | $12.8M | $628K | $12.2M | Oct 30 |
By fiscal year
| Year | Revenue | Gross margin | Operating income | Net income | Net margin | EPS | Op. cash flow | Capex | Free cash flow | Buybacks | Dividends paid |
|---|---|---|---|---|---|---|---|---|---|---|---|
| FY2025 · to Dec 31 | $418.6M | 82.6% | $63.9M | $48.6M | 11.6% | 0.32 | $74M | — | — | $0 | — |
| FY2024 · to Dec 31 | $348.9M | 82.8% | $58.9M | $42.4M | 12.2% | 0.28 | $66.2M | — | — | $0 | — |
| FY2023 · to Dec 31 | $321.5M | 83.0% | $37.1M | $58.2M | 18.1% | 0.37 | $26.8M | $2M | $24.8M | $9.5M | — |
| FY2022 · to Dec 31 | $267.8M | 82.0% | −$14.7M | −$30.2M | -11.3% | -0.33 | −$17.9M | $1.5M | −$19.4M | $0 | — |
| FY2021 · to Dec 31 | $242M | 83.6% | −$7.1M | −$10.3M | -4.2% | -0.15 | −$2M | $3.2M | −$5.2M | $0 | — |
| FY2020 · to Dec 31 | $248.2M | 84.2% | −$45.4M | −$49.3M | -19.9% | -0.77 | −$30.3M | — | — | $900K | — |
Every number comes from MIMEDX GROUP, INC.'s own XBRL-tagged filings with the SEC, not a data vendor. Quarters marked derived are the fiscal year minus the three reported quarters, the same way every data provider computes Q4. Restated figures replace originals as later filings arrive.